BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28428185)

  • 21. Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010.
    Head MG; Fitchett JR; Cooke MK; Wurie FB; Atun R; Hayward AC; Holmes A; Johnson AP; Woodford N
    J Antimicrob Chemother; 2014 Feb; 69(2):548-54. PubMed ID: 24038777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic analysis of funding awarded to institutions in the United Kingdom for infectious disease research, 1997-2010.
    Head MG; Fitchett JR; Moore DA; Atun R
    JRSM Open; 2015 Mar; 6(3):2054270415577056. PubMed ID: 25893108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Funding healthcare-associated infection research: a systematic analysis of UK research investments, 1997-2010.
    Head MG; Fitchett JR; Holmes AH; Atun R
    J Hosp Infect; 2014 Jun; 87(2):84-91. PubMed ID: 24815767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding.
    Carter AJ; Nguyen CN
    BMC Public Health; 2012 Jul; 12():526. PubMed ID: 22800364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited alignment of publicly competitive disease funding with disease burden in Japan.
    Nomura S; Yoneoka D; Tanaka S; Makuuchi R; Sakamoto H; Ishizuka A; Nakamura H; Kubota A; Shibuya K
    PLoS One; 2020; 15(2):e0228542. PubMed ID: 32040510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomes.
    Glover M; Buxton M; Guthrie S; Hanney S; Pollitt A; Grant J
    BMC Med; 2014 Jun; 12():99. PubMed ID: 24930803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational allocation of Australia's research dollars: does the distribution of NHMRC funding by National Health Priority Area reflect actual disease burden?
    Mitchell RJ; McClure RJ; Olivier J; Watson WL
    Med J Aust; 2009 Dec 7-21; 191(11-12):648-52. PubMed ID: 20028294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic analysis of funding awarded for norovirus research to institutions in the United Kingdom, 1997-2010.
    Head MG; Fitchett JR; Atun R
    J R Soc Med; 2014 Mar; 107(3):110-5. PubMed ID: 24262891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resource allocation to brain research in Europe (RABRE).
    Sobocki P; Lekander I; Berwick S; Olesen J; Jönsson B
    Eur J Neurosci; 2006 Nov; 24(10):2691-3. PubMed ID: 17156195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NSFC health research funding and burden of disease in China.
    Xu G; Zhang Z; Lv Q; Li Y; Ye R; Xiong Y; Jiang Y; Liu X
    PLoS One; 2014; 9(11):e111458. PubMed ID: 25369330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Neurological Disorders Collaborator Group
    Lancet Neurol; 2017 Nov; 16(11):877-897. PubMed ID: 28931491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Burden of cancer in China: data on disability-adjusted life years].
    Shi J; Zhang Y; Qu C; Zhang K; Guo L; Dai M; He J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Apr; 49(4):365-9. PubMed ID: 26081549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investments in sexually transmitted infection research, 1997-2013: a systematic analysis of funding awarded to UK institutions.
    Head MG; Fitchett JR; Cassell JA; Atun R
    J Glob Health; 2015 Dec; 5(2):020405. PubMed ID: 26322229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burden of disease, research funding and innovation in the UK: Do new health technologies reflect research inputs and need?
    Ward D; Martino O; Packer C; Simpson S; Stevens A
    J Health Serv Res Policy; 2013 Apr; 18(1 Suppl):7-13. PubMed ID: 27552774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?
    Luengo-Fernandez R; Leal J; Gray AM
    Eur J Neurol; 2012 Jan; 19(1):149-54. PubMed ID: 21951976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping Investments and Published Outputs in Norovirus Research: A Systematic Analysis of Research Funded in the United States and United Kingdom During 1997-2013.
    Head MG; Fitchett JR; Lichtman AB; Soyode DT; Harris JN; Atun R
    J Infect Dis; 2016 Feb; 213 Suppl 1(Suppl 1):S3-7. PubMed ID: 26744430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health burden and funding at the Centers for Disease Control and Prevention.
    Curry CW; De AK; Ikeda RM; Thacker SB
    Am J Prev Med; 2006 Mar; 30(3):269-76. PubMed ID: 16476645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between government research funding and the cancer burden in South Korea: implications for prioritising health research.
    Jung YL; Yoo HS; Kim ES
    Health Res Policy Syst; 2019 Dec; 17(1):103. PubMed ID: 31870382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997-2010.
    Head MG; Fitchett JR; Cooke MK; Wurie FB; Atun R
    BMJ Open; 2013 Dec; 3(12):e003362. PubMed ID: 24327360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Mokdad AH; Forouzanfar MH; Daoud F; Mokdad AA; El Bcheraoui C; Moradi-Lakeh M; Kyu HH; Barber RM; Wagner J; Cercy K; Kravitz H; Coggeshall M; Chew A; O'Rourke KF; Steiner C; Tuffaha M; Charara R; Al-Ghamdi EA; Adi Y; Afifi RA; Alahmadi H; AlBuhairan F; Allen N; AlMazroa M; Al-Nehmi AA; AlRayess Z; Arora M; Azzopardi P; Barroso C; Basulaiman M; Bhutta ZA; Bonell C; Breinbauer C; Degenhardt L; Denno D; Fang J; Fatusi A; Feigl AB; Kakuma R; Karam N; Kennedy E; Khoja TA; Maalouf F; Obermeyer CM; Mattoo A; McGovern T; Memish ZA; Mensah GA; Patel V; Petroni S; Reavley N; Zertuche DR; Saeedi M; Santelli J; Sawyer SM; Ssewamala F; Taiwo K; Tantawy M; Viner RM; Waldfogel J; Zuñiga MP; Naghavi M; Wang H; Vos T; Lopez AD; Al Rabeeah AA; Patton GC; Murray CJ
    Lancet; 2016 Jun; 387(10036):2383-401. PubMed ID: 27174305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.